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http:WHAT THIS PAPER ADDS
An operation involving microsurgical lymphovenous shunts was designed for decompressing the lymphedem-
atous limb of the accumulated lymph by directing its ﬂow to the venous system distally to the site of lymphatic
obstruction. It is performed using a microsurgical technique, between the limb afferent lymphatics and
superﬁcial veins. This study presents the 45-year experience of one surgeon based on over 1100 lympho-venous
shunts in the treatment of postinﬂammatory, postsurgical, hyperplastic and idiopathic types of lymphedema of
the lower limbs. Improvement of between 30% and 80%, depending on the type of lymphedema, was achieved
in the 5-year follow-up, measured by decrease in limb circumference and increase in joint ﬂexing.Rationale: The use of microsurgical lymphovenous shunts is one of the generally accepted treatments for limb
lymphedema.
Aim: The 45-year personal experience of one surgeon in indications, technique and results of lymphovenous
shunt operations in lower limb lymphedema of varying etiology is presented.
Material: One thousand three hundred patients were followed up in the period 1966e2011. Patients were
classiﬁed into groups according to the etiology of lymphedema as postinﬂammatory/posttraumatic, postsurgical,
idiopathic and hyperplastic. Decrease in limb circumference, heaviness and pain, and increase in joint ﬂexing
were evaluated.
Results: The most satisfactory results, reaching 80e100% improvement, were obtained in the congenital non-
hereditary hyperplastic lymphedema group, with large lymphatics not previously damaged by infection. Results
were also satisfactory in the group of cancer patients after iliac lymphadenectomy, reaching 80%. A less
satisfactory outcome was observed in the postinﬂammatory group, not exceeding 30e40%. In idiopathic
lymphedema results were satisfactory in only a few cases.
Conclusions: Patients with lymphedema with local segmental obstruction but still partly patent distal lymphatics
and without an active inﬂammatory process in the skin, subcutaneous tissue and lymph vessels present
satisfactory results.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The need for effective treatment of lymphedema of the
limbs has become increasingly important, as the prevalence
of this condition after soft tissue bacterial and parasitic
infections, traumatic bone fractures and oncological surgery
is steadily increasing. The statistics from WHO and other
sources oscillate between 100 and 300 million of the world
population, varying between different continents. The
increasing longevity of patients treated for cancer with late./fax: þ48 22 668 53 16.
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//dx.doi.org/10.1016/j.ejvs.2012.11.025post-treatment development of lymphedema adds to these
statistics. The contemporary therapy for lymphedema is
based upon a combination of manual and pneumatic
massage, elastic garments, prophylactic antibiotic adminis-
tration for prevention of dermatolymphangioadenitis (DLA),
and surgical procedures.1
An operation involving microsurgical lymphovenous
shunts was designed for decompressing the lymphedema-
tous limb of the accumulated lymph and directing its ﬂow
to the venous system distally to the site of lymphatic
obstruction. This operation mimicks the natural anasto-
mosis of the thoracic duct with the subclavian vein, by the
creation of microsurgical shunts between the lymphatics
and veins. The other type of operation used is debulking
surgery, but the microsurgical shunt procedure appears to
have the advantage of creating a naturalistic lymph outﬂow
W.L. Olszewski 283pathway. Evaluation of the efﬁcacy of this technique
involving large numbers of patients was needed, with the
indications adjusted to lymphedema of different etiologies
and various stages of its advancement.
Lymphovenous shunts were experimentally attempted
by us in 1966 and the ﬁrst clinical operations were per-
formed soon after.2e5 Since that time, various modiﬁca-
tions of this operation have been tried at different
centers.6e13 Herein, we present the 45-year experience of
one surgeon/one center in the treatment of lymphedema
of the lower limbs based on over 1100 patients operated
upon in the period 1966e2011. The results obtained in
patients with lymphedema of various etiological types are
presented. Indications for the use of lymphovenous shunts
and methods of assessment based on the evaluated
material are described.
PATIENTS AND METHODS
Patients
A total of 1343 consecutive patients with unilateral lym-
phedema of lower limb were admitted to our center in the
period 1966e2011. There were 986 females and 357 males,
and of them 26 patients were aged 7e16 years and the
remaining 24e68 years. Patients were classiﬁed into groups
according to the etiology of lymphedema: postinﬂammatory
and posttraumatic, postsurgical, idiopathic and hyper-
plastic.14 This classiﬁcation was based on past history,
clinical picture, and lipiodol and, more recently, isotope
lymphograms. There were no cases of inherited lymphe-
dema included as a lack of lymphatic collectors precludes
performing the lymphovenous shunt. To exclude cases with
venous thrombosis, contrast venography and more recently
Doppler color venography was performed.
Inclusion criteria were: a) edema developing after inci-
dents of dermatitis with recurrent attacks of DLA referred to
as cellulitis and erysipelas; b) edema after major trauma of
soft tissues with hematoma and inﬂammation; c) edema
after lymph node removal and/or irradiation (after hyster-
ectomy, inguinal lymphadenectomy), or saphenous vein
harvesting for aorto-coronary bypass; d) cases with slow
symptomless development of edema e so-called primary or
idiopathic edema; and e) congenital edema (non-genetic)
with dilated actively contracting lymphatics e hyperplastic
lymphedema. Exclusion criteria were: congenital genetically
transferred lymphedema, lipedema, chronic venous stasis,
cardiac and kidney edema, rheumatoid arthritis, and acute
inﬂammatory soft tissue changes.
There were 850 patients in the postinﬂammatory and
posttraumatic group. In the postsurgical group there were
302, including 136 after hysterectomy and radiotherapy due
to uterine cancer and 66 after inguinal and iliac lymph node
removal because of melanoma or seminoma. There were
165 patients in the idiopathic group and 26 in the hyper-
plastic group. Of the total number of admitted patients,
1176 gave signed consent for the lymphovenous shunt
operation. They met the following criteria: gradually
increasing uncontrolled edema of the limb, in stages I to IV,with hyperkeratosis and ﬁbrosis of the skin and lympho-
graphic signs of lymph stasis. Of these, 960 patients were
followed for at least 5 years, including 218 who showed up
occasionally for check-ups over 10e40 years. None of the
investigated patients consistently used additional types of
edema therapy, which could affect the results. The purchase
of elastic materials and more recently manual or pneumatic
compression equipment is not reimbursed by the Polish
insurance system and most patients could not afford to buy
them.We monitored patients with respect to any additional
therapy at each periodic check-up. The study was approved
by the Warsaw Medical University ethics committee.
Study setting
Patients were divided into four groups according to the
etiology of lymphedema. Each of these groups was strati-
ﬁed into stages based on the advancement of limb
anatomical and lymphographic changes. With the exception
of the hyperplastic lymphatics group who were all aged 7e
16, there was an even distribution of age across all etiology
groups and stages of the disease.
All patients had either lymphodeno-venous or lympha-
tico-venous shunt performed in the groin. Selection of the
type of shunt depended on presence or absence (atrophy,
ﬁbrosis) of inguinal nodes. In both types of drainage oper-
ation, the lymph ﬂow through the shunt should have been
similar, as at least 3e5 afferent lymphatics carry lymph to
the groin region.
The initial follow-up period after the operationwas 5 years.
There were also small groups followed for periods of 10, 20,
30 and 40 years. During the 5-year follow up patients were
assessed every 6 or 12 months. Patient compliance was
around 80%. Those with longer follow up of above 10 years
appeared for assessment occasionally at different time
intervals. Thirteen patients whose body mass index had
increased at the end of follow up by 10% were excluded from
evaluation. This low number could not skew the results.
Clinical staging
Staging was based on evaluation of the level of edema
embracing the limb from foot to groin, and the advance-
ment of skin keratosis and ﬁbrosis. Brieﬂy, in stage I pitting
edema was limited to the foot, in stage II pitting edema
affected the foot and lower half of the calf, in stage III foot
and calf were involved with hard foot and ankle area skin,
and in stage IV the whole limb was edematous with foot
and calf skin hyperkeratosis and toe papillomatosis.14,15
Clinical staging was correlated with the lymphographic
pictures of lymph stasis.
Preoperative imaging and staging
Visualization of the lymphatic system is indispensable
before planning the lymphovenous shunt. All patients had
lymphography carried out. In the period up to 1988, an oily
contrast medium was injected into a cannulated lymphatic
on the dorsum of the foot. Since 1988, with isotope
lymphography available, Tc99m Nanocoll (aggregated
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and into the sole (deep system). Gamma camera pictures
provided information on tracer absorption, afferent
lymphatics’ outline, and time for tracer to reach inguinal
lymph nodes and their outline. According to our classiﬁca-
tion lymphoscintigraphy in stage I lymphedema reveals
spread of tracer in the foot, a faint outline of superﬁcial
lymphatics and small inguinal lymph nodes visualized within
30 min of isotope injection. In stage II, there is spread of
tracer in the foot and lower part of calf, interrupted outline
of narrow lymphatics, and a few small inguinal nodes with
irregular outline. In stage III there are no collecting but only
minor lymphatics visible and inguinal nodes reveal irregular
outline after more than 2 h following isotope injection.
Stage IV is characterized by spread of tracer in minor
lymphatics and tissue space of the foot and calf without
visualization of collecting lymphatics and nodes. Lack of
visualization of lymphatics did not preclude the shunt
operation, as there are thigh lymphatics draining into the
inguinal lymph nodes that are not shown after injection of
tracer into the foot tissues.
Duplex ultrasound phlebography of limb superﬁcial and
deep venous systems and pelvic veins was performed in all
cases to exclude recent or past thromboses.Microsurgical lymphovenous shunt operations
A total of 1176 patients had lymph node-saphenous vein
(LNSV) or lymphatic vessel-saphenous vein (LVSV) anasto-
mosis performed (Table 1, Fig. 1). Details of the technique
have been described previously,3e5 and are outlined as
follows.Table
in vari
Type
No.
Stag
I
II
III
IVLNSV: The groin skin was incised. One of the inguinal
lymph nodes was cut transversely across its long axis
between the ﬁrst distal and second third. After
venotomy, the lumen of the vein was rinsed with
heparin saline solution, and the distal and proximal
segments of the vein were also be ﬁlled with heparin
saline. Only the capsule of the node without
parenchyma was stitched to the vein wall, interrupted
6-0 or 7-0 DEXON being the most suitable suturing
material. An operating microscope with
magniﬁcation8e12.5was used during dissection and
suturing. After the release of vascular clamps, light
massage of the distal part of the limb was instituted to
increase the lymph ﬂow through the anastomosis.1. Number of patients undergoing lymph node-to-saphenous vein (LNSV
ous types of lymphedema in the period 1966e2011 (n ¼ 1176).
Postinﬂammatory Postsurgi
of patients 770 260
e LNSV LVSV LNSV LVSV
230 22 92 38
218 78 62 21
112 20 34 13
90 0 e eSystemic heparinization was avoided because of the
risk of bleeding from the suture line. Thrombotic
complications have, so far, not been observed. Suction
drainage of the wound was instituted for 48 h.
LVSV: Two types of operative technique were used.
One was an end-to-end anastomosis of a dilated
lymph vessel with a vein of the same caliber. To avoid
a stricture at the site of anastomosis, a short length of
tubing was inserted into the lymph vessel and vein at
the time of suturing and removed immediately before
completion of the anastomosis through an incision in
the proximal part of the vein. Technically simpler was
the procedure of invagination of the lymph vessel into
the vein. In all types of LVSV special care was taken
not to deprive the lymph vessel of its blood supply (!).
The other operation was transmural implantation of
a lymph vessel into the vein. In order to make an
opening in the vein and to introduce the lymphatic
vessel, needles of two different types, a straight one
and an angled one, were used. They have a diameter
of 12.15 or 18 mm, and a length of 140 mm. These
needles have a groove 30 mm long. The lymphatic
vessel was dissected carefully mostly by blunt
separation with scissors. Each isolated lymphatic
vessel (from 3 to 9 in number) was held by a traction
loop of no. 1 or 2 black silk. A segment of the vein at
an appropriate level was held by two traction loops of
umbilical tape. A straight or angled grooved venous
needle of adequate diameter was inserted into the
great saphenous vein. The distal lymphatic stump was
exposed. A 7-0 double arterial curved needle with
prolene suture was used. One of the two needles was
passed from outside, through the lymphatic wall, and
into the lumen. The same needle was then inserted
into the vein oriﬁce through the grooved venous
needle from inside to the outside of the wall, coming
out at a distance of 2 mm from the oriﬁce. The
lymphatic vessel was carefully pulled into the vein.
After completion of the ﬁrst anastomosis other
lymphatics were implanted.Postoperative evaluation
Extremity measurements were taken preoperatively and
were subsequently repeated at 6- and 12-month intervals.
In some cases the 6-month measurements were omitted.
Physical evaluation included: (a) leg circumference, (b)) or lymph vessel-to-saphenous vein (LVSV) shunt operation
cal Idiopathic Hyperplastic
120 26
LNSV LVSV LNSV LVSV
22 20 e e
48 2 e e
e e 24 2
e e e e
Figure 1. Lympho-nodo-venous and lymphatico-venous microsurgical shunts. Various types of anastomosis can be performed. FV-femoral
vein, ILN-inguinal lymph node, SV-saphenous vein, CAPS-capsule, LVS-lymphatic vessels. Data on ILN to SV and LVS invaginated to SV
shunts are presented in this article.
W.L. Olszewski 285ﬂexing angle in the ankle and knee joints, and (c) limb pain
sensation after day-long upright position.
(a) Standardized circumferential measurements were
made during morning hours at three locations on the
edematous and contralateral normal limb: dorsum of
foot, mid-calf and mid-thigh. The circumference ratio
edema:normal was calculated. The post-treatment
measurements were compared to the initial baseline
circumference values. Decrease by at least 2 cm at all
levels of the edematous limb was considered to be
signiﬁcant. The body mass index was estimated at the
start of the study and at the end of follow up to adjust
the circumference changes.
(b) Flexing and extension at the ankle and knee joints were
measured using an angle gauge. Increase in foot ﬂexing
by 15 and knee by 30 was considered signiﬁcant.
(c) In order to specify the kind of abnormal feeling
(heaviness, pain) in the limb, the McGill Pain
Questionnaire was applied, with dull, sore, hurting,
aching, heavy rated 1e5.16 To assess the intensity of
limb pain the routine numeric rating scale of 1e10 was
used: 0 represented no pain at all, 1e5 moderate, 6e9
worse, while 10 was the worst imaginable pain.
The postoperative limb evaluation criteria were as
follows: circumference decrease by 2 cm ¼ 1 point, increase
in ﬂexing limb joints by 30 ¼ 1 point, change from heavy to
dull feeling ¼ 1 point, and decrease of pain at day end to
1e3 ¼ 1 point. Improvement ranged from 2 to 4 points.
To evaluate directly the function of the lymphovenous
shunt, postoperative lymphoscintigraphic imaging oflymphaticswithmanual venous occlusion above the shunt for
prevention of fast dragging by the blood stream was done in
20 cases of each group within 90e360 days of the operation.Statistics
Data are presented as percentages of improvement of clinical
parameters.To assess individual results, the Student t-test for
pairs was applied. Differences between results in the lym-
phedema groups, and between the LNSV and LVSV shunts,
were evaluated with use of the ManneWhitney test. The
differences were considered signiﬁcant at the level of<0.05.RESULTS
Clinical results of 5-year follow up
(a) Postinﬂammatory lymphedema
Improvement in stages I and II was observed in 29%e
42% within rating 2e4 (Table 2). In patients with
improvement the circumference of the limb decreased at all
levels by a minimum of 2 cm. The circumference ratio (CR)
of the edematous to normal limb decreased at foot level
from 1.5  0.5 to 1.3  0.4 (p < 0.05), at mid-calf from
2.8  1.4 to 2.5  1.4 (p < 0.05) and at mid-thigh from
1.8  08 to 1.6  0.8 (p < 0.05) (Fig. 2). In patients rated
0e1 (no improvement) there was no increase in CR and in
most cases alleviation of subjective symptoms was
observed. Joint mobility increased in ankle from 25  10
and knee 60  30 before operation to 35  10 and
286 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 3 March/201390  20, respectively (p < 0.05) (Fig. 3). Type of pain
changed from heavy to dull in 80% of cases and severity
decreased from 1e5 to 1e2 (p < 0.05). There were no
differences in results between the two types of shunt, LNSV
and LVSV. No statistically signiﬁcant improvement was seen
at stages III and IV.
(b) Postsurgical lymphedema
Improvement was observed in stages I and II in 49%e
80% within rating 2e4 (Table 2). This was signiﬁcantly
higher than in the postinﬂammatory/posttrauma group
(p < 0.05). The CR of the edematous to normal limb
decreased in the improved cases at foot level from
1.3  0.5 to 1.1  0.5 (p < 0.05), mid-calf from 1.8  1.2 to
1.6  0.8 (p < 0.05) and mid-thigh from 2.0  0.6 to
1.7  0.8 (p < 0.05) (Fig. 2). Joint mobility increased in
ankle from 35  15 and knee 70  20 before operation to
45  10 and 90  20, respectively (p < 0.05) (Fig. 3). Type
of pain changed from heavy to sore in 60% of cases and
severity decreased from 1e5 to 1e2 (p < 0.05). There were
no differences in results between the LNSV and LVSV
shunts. Patients at stage III did not show improvement.
(c) Idiopathic lymphedema
Improvement was observed in stage I in 33%e41% and
stage II in 0%e14% within rating 2e3 (Table 2). The CR of
the edematous to normal limb decreased in the improved
cases at foot level from 1.3  0.5 to 1.2  0.4 (p < 0.05)
and at mid-calf from 1.8  0.4 to 1.6  0.8 (p < 0.05)
(Fig. 2). Mid-thigh was usually not affected. Interestingly,
there was no increase in CR in patients without improve-
ment, and alleviation of subjective symptoms was observed
in some. Ankle joint mobility was not restricted, whereas in
the knee it increased from 80  30 before operation to
90  20 (p < 0.05) (Fig. 3). Type of pain changed from
hurting to dull in 80% of cases and severity decreased from
1e5 to 1e2 (p < 0.05). There were no differences in results
between the LNSV and LVSV shunts. There were no cases in
stage III or IV as this form of lymphedema only occasionally
proceeds to the advanced stages.
(d) Hyperplastic lymphedema
Twenty-four patients were followed up. They were all in
stage III. Their lymphatics had a diameter of 5 mm and evenTable 2. The 5-year follow-up results of L
NSV (lymph node-saphenous vein) and LVSV (lymph vessel-saphenou
etiologies in the period 1966e2011 (n ¼ 960, % of patients with imp
Postinﬂammatory Po
No. of patients 625 19
Stage LNSV % LVSV % LNSV % LVSV %
I 210 32 12 42 60 85 65 82
II 192 29 55 30 36 55 25 49
III 97 3 14 0 10 0 e e
IV 45 0 0 0 0 e e ewider. Improvement was observed in 82%e100% (Table 2).
The CR decreased in the improved cases in the foot from
1.6  0.5 to 1.1  0.5 (p < 0.05), at mid-calf from 2.2  0.3
to 1.8  0.9 (p < 0.05) and at mid-thigh from 2.4  0.6 to
2.1  0.5 (p < 0.05) (Fig. 2). The patients’ joint mobility was
not restricted nor did they suffer from pain.
Follow up of 10e40 years
A total of 218 patients of all etiologies presented for eval-
uation during a follow-up period of 10e40 years (Table 3).
In the postinﬂammatory lymphedema group, good results
rated 1e4 ranged from 19% to 50%. Patients with post-
surgical lymphedema who survived cancer treatment
revealed initial improvement and further stabilization of
limb size. In the idiopathic group, only six patients appeared
for evaluation after 10 years. Two of them reported stabi-
lization of the disease. Three patients with hyperplastic
lymphedema reported permanent improvement. Overall,
we did not observe progression of the disease in any group
over the follow-up time.
DISCUSSION
The rationale for performing lymphovenous shunts in the
treatment of lymphedema requires an updated knowledge
of the pathophysiology of this condition. Lymphedema of
limbs develops as a consequence of damage to lymphatic
vessels. This is followed by stasis of the tissue ﬂuid and
lymph in skin, subcutaneous tissue, muscular fascia and
muscles.17 The kinetics of the process and efforts to control
it depend on the causative factors.
There are several etiological factors responsible for the
development of lymphedema. The most common causes of
damage to the lymphatics are bacterial infection, trauma,
and cancer surgery and radiotherapy. Skin staphylococcal
infections bring about destruction of the lymphatic endo-
thelial and muscular cells. The spontaneous contractility of
lymphangions becomes impaired or is totally lost and lymph
ﬂow is stopped.18 Moreover, ﬁbroblasts replace the
lymphoid tissue in lymph nodes. Fibrotic nodes create
further resistance for lymph ﬂow from the proximal part of
the extremity.19 Trauma of soft tissues and fractures and
the accompanying long-lasting local inﬂammatory process
also impair lymphatic drainage, and stasis of tissue ﬂuid and
lymph develops.20 Removing iliac and inguinal nodes in
melanoma, seminoma or uterine cancer and scars formed
after local irradiation obstruct lymph ﬂow from the entires vein) shunt operations in patients with lymphedema of various
rovement).
stsurgical Idiopathic Hyperplastic
6 115 24
LNSV % LVSV % LNSV % LVSV %
10 33 12 41 e e e e
36 14 2 0 e e e e
e e e e 24 82 2 100
e e e e e e e e
Figure 2. Changes in ankle and knee joint ﬂexion after lymphovenous shunt operation in patients with clinical improvement rating 2e4 in
the 5-year follow up. Values are means  SD. *p < 0.05.
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lymph ﬂow impairment is located in small lymphatics, and
even minor obstruction in collecting lymphatics or nodes
causes lymph stasis.
In each of these groups, the prognosis is very different.
The common denominator for all forms of lymphedema is
tissue ﬂuid and lymph stasis. There are several conservative
methods for evacuation of stagnant tissue ﬂuid and lymph;Figure 3. Lymphoscintigraphy in a patient with posttraumatic lymphed
vessel to small subcutaneous vein was performed. Slow blood ﬂow alhowever, what is basically needed is the restoration of
anatomical lymph outﬂow pathways. Lymph node-to-vein
and lymphatic-to-vein microsurgical shunts2e5 have been
considered as one of the solutions. We designed the
microsurgical lymphovenous shunts in the 1960s and have
performed this operation in over 1100 cases since. In
contrast to other authors, we have assessed the results in
lymphedema stratiﬁed according to the cause of lymphema of the left lower limb 6 months after a microsurgical lymph
lowed to visualize isotope ﬂowing into the vein (circle).
Table 3. The 10e40-year follow-up results of LNSV and LVSV shunt operations in patients with lymphedema of various etiologies in the
period 1966e2011 (n ¼ 218, % of improvement).
Type Postinﬂammatory Postsurgical Idiopathic Hyperplastic
No. of patients 137 72 6 3
Years of follow up LNSV % LVSV % LNSV % LVSV % LNSV % LVSV % LNSV % LVSV %
10 66 15 25 20 26 77 12 66 6 33 e e e e e
20 21 24 11 45 12 50 8 50 e e e e e e e e
30 8 50 4 50 6 66 6 50 e e e e e e e e
40 2 50 e e 2 50 e e e e e e 3 100 0 e
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the etiology of lymphedema: postinﬂammatory/post-
traumatic, postsurgical, idiopathic or hyperplastic. The old
type of classiﬁcation into primary (aplasia, hypoplasia,
precox and tarda) and secondary is no longer considered
tenable. It was based only on oily contrast lymphographic
pictures from the 1960s. Contemporary imaging and
immunohistological pictures show that in so-called primary
lymphedema the lymphatics are damaged by invasive
factors destroying endothelial and muscle cells. They reveal
a normal developmental structure of the vessel; however,
with secondary pathological changes in the wall and
lumen.21 The idiopathic group is restricted to the cases of
unknown etiology. The frequency rate of this condition is
decreasing with progress in visualization and immunohis-
tochemical techniques. We did not include in the study
congenital lymphedema cases such as Milroy’s disease, as
lack of lymphatic collectors precludes performing a shunt in
such cases.
The most satisfactory results were obtained in young
patients with congenital non-hereditary hyperplastic lym-
phedema, with large lymphatics not previously damaged by
infection. The improvement rate reached 80e100%
according to the clinical evaluation criteria. There was
a decrease in the limb volume after operation and the
proportions of the swollen to the healthy limb in the still
growing patients were preserved. Results were also satis-
factory in the group with tumors requiring iliac and inguinal
lymphadenectomy, with improvement in 80% of cases. In
these patients the afferent lymphatics were not damaged
by infection and their contractility was preserved. In
contrast to these two groups, results in the post-
inﬂammatory group with previous infections were less
satisfactory, not exceeding 30e40%. Lymphograms revealed
in this type of lymphedema fragmentation of the lymphatic
outline and destruction of the lymph node architecture. This
was mostly seen in advanced stages. In the idiopathic
lymphedema group, obstruction to the lymph ﬂow was
located in the minor peripheral lymphatics. This is why the
results were the least satisfactory, although improvement
was observed in some cases.
The presented statistics prove the efﬁcacy of microsur-
gical lymphovenous shunts in a signiﬁcantly large group of
patients. The value of our data has been strengthened by
the fact that patients were not treated by other means such
as massages and elastic materials. Moreover, we controlled
attacks of DLA with antibiotics, preventing further damage
to lymphatics and increase in lymph stasis.Why the most satisfactory results were limited to the
postsurgical and hyperplastic groups can be explained by
analysis of the primary pathological factors causing lymphe-
dema. The peripheral lymphatic system is exposed to infec-
tions and drains away microorganisms as well as antigens
from traumatized tissue. Dermatitis (erysipelas, staphylo-
coccal infections) and trauma to limb soft tissues destroy the
peripheral lymphatics.14 Moreover, microbes remain in the
affected tissues and evoke recurrent inﬂammatory reac-
tions.20 Despite the decompression of lymphatics by lym-
phovenous shunts, the destructive process is proceeding.This
is why in the postinﬂammatory/posttraumatic group less
satisfactory results were to be expected.
The overall statistics in the pertinent literature point to
good and sometimes even excellent results for the lympho-
venous shunts.22e37,39e47 The number of performed opera-
tions around the world has reached hundreds of thousands.
Themain concern raised by several authors is the limited time
of function of the newly created anastomoses.38 As
mentioned before, we observed this mainly in the post-
inﬂammatory group operated upon shortly after an inﬂam-
mation episode or in those with a chronic skin inﬂammation.
Unfortunately, in most reports there was no stratiﬁcation of
the operated cases into groups according to the etiology of
lymphedema. Our experience points to the necessity of
detailed analysis of the causative factors, as the latent
inﬂammation following erysipelas, non-healing wounds and
cellulitis may have an effect upon the long-term results of
lymphovenous shunts.
Evaluation of the clinical results of lymphovenous shunts
is difﬁcult because of: a) low show-up rate of patients for
periodic follow up because of stabilization of the state of
the limb; b) subjective assessments by patients of limb
heaviness/pain carried out over years; c) lack of visualiza-
tion methods due to fast venous blood ﬂow diluting the
lymph tracer; (d) supplementary multimodal therapy such
as massaging, elastic support, long-term antibiotic prophy-
laxis used in most centers. We were able to avoid this last
problem by prospectively planning a follow up without
additional therapeutical modalities. With respect to limb
measurement, we found that the most consistent evalua-
tion parameters were leg circumference using self-adhering
tape, increased ﬂexing in the ankle and knee joints, and
subsidence or decrease of limb pain during long-lasting
upright position. Additional parameters such as time of
appearance of radioactivity over liver after Nanocoll toe
web injection before and after shunt operation did not
correlate with the clinical evaluation. Postoperative
W.L. Olszewski 289lymphoscintigraphic imaging of lymphatics with venous
occlusion above the shunt showed occasional presence of
radioactive tracer in the draining vein (Fig. 3).
Based on the long-term follow up of the lymphovenous
shunt operation in the lower limbs, we suggest the
following indication for further practice: lymphedema at an
early stage (I and II) of postinﬂammatory, postsurgical or
hyperplastic type, with at least one thigh lymphatic and
a single inguinal or iliac lymph node visible on the stress
lymphoscintigraphy (performed during limb pneumatic
massage or after standard time walking). Limited indications
include: stages III and IV with no lymphatics or nodes on
lymphoscintigraphy but presumably patent thigh
lymphatics. No indication is given in the case of idiopathic
lymphedema with soft skin, pitting edema and lack of
lymphatic structures on lymphoscintigraphy. Contraindica-
tions for operation are recent attacks of DLA and skin ulcers.
Taken together, the microsurgical lymph node or
lymphatic vessel to vein shunts have their established
position among the therapeutic modalities for lymphedema
of lower limbs; however, the indications should be
restricted to lymphedema with local segmental obstruction
but still partly patent distal lymphatics and without active
inﬂammatory processes in skin, subcutaneous tissue and
lymph vessels. Satisfactory clinical results such as decrease
in limb girth and easy ﬂexing in limb joints were observed in
30%e80%, depending on the etiology of lymphedema.CONFLICT OF INTEREST/FUNDING
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